EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. MRK

Equity Profile

MRK

Merck & Co., Inc.

Health CarePharmaceuticals$351.3B market cap

Earnings scorecard

Last 75Q

EPS beat streak

20Q

EPS beat rate

88%

Avg EPS surprise

+6.69%

Avg 1-day reaction

-0.40%

Earnings history

76 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingOct 29, 2026————Preview
Q2-2026Aug 4, 2026$-0.26$-0.13+50.57%+0.18%Preview
Q1-2026Apr 30, 2026$-1.47$-1.28+15.46%-1.60%Preview
Q4-2025Feb 3, 2026$2.03$2.04+0.59%+2.18%Preview
Q3-2025Oct 30, 2025$2.36$2.58+9.32%-0.35%Preview
Q2-2025Jul 29, 2025ProPreview
Q1-2025Apr 24, 2025ProPreview
Q4-2024Feb 4, 2025ProPreview
Q3-2024Oct 31, 2024ProPreview
Q2-2024Jul 30, 2024ProPreview
Q1-2024Apr 25, 2024ProPreview
Q4-2023Feb 1, 2024ProPreview
Q3-2023Oct 26, 2023ProPreview
Q2-2023Aug 1, 2023ProPreview
Q1-2023Apr 27, 2023ProPreview
Q4-2022Feb 2, 2023ProPreview
Q3-2022Oct 27, 2022ProPreview
Q2-2022Jul 28, 2022ProPreview
Q1-2022Apr 28, 2022ProPreview
Q4-2021Feb 3, 2022ProPreview
Q3-2021Oct 28, 2021ProPreview
Q2-2021Jul 29, 2021ProPreview
Q1-2021Apr 29, 2021ProPreview
Q4-2020Feb 4, 2021ProPreview
Q3-2020Oct 27, 2020ProPreview
Q2-2020Jul 31, 2020ProPreview
Q1-2020Apr 28, 2020ProPreview
Q4-2019Feb 5, 2020ProPreview
Q3-2019Oct 29, 2019ProPreview
Q2-2019Jul 30, 2019ProPreview
Q1-2019Apr 30, 2019ProPreview
Q4-2018Feb 1, 2019ProPreview
Q3-2018Oct 25, 2018ProPreview
Q2-2018Jul 27, 2018ProPreview
Q1-2018May 1, 2018ProPreview
Q4-2017Feb 2, 2018ProPreview
Q3-2017Oct 27, 2017ProPreview
Q2-2017Jul 28, 2017ProPreview
Q1-2017May 2, 2017ProPreview
Q4-2016Feb 2, 2017ProPreview
Q3-2016Oct 25, 2016ProPreview
Q2-2016Jul 29, 2016ProPreview
Q1-2016May 5, 2016ProPreview
Q4-2015Feb 3, 2016ProPreview
Q3-2015Oct 27, 2015ProPreview
Q2-2015Jul 28, 2015ProPreview
Q1-2015Apr 28, 2015ProPreview
Q4-2014Feb 4, 2015ProPreview
Q3-2014Oct 27, 2014ProPreview
Q2-2014Jul 29, 2014ProPreview
Q1-2014Apr 29, 2014ProPreview
Q4-2013Feb 5, 2014ProPreview
Q3-2013Oct 28, 2013ProPreview
Q2-2013Jul 30, 2013ProPreview
Q1-2013May 1, 2013ProPreview
Q4-2012Feb 1, 2013ProPreview
Q3-2012Oct 26, 2012ProPreview
Q2-2012Jul 27, 2012ProPreview
Q1-2012Apr 27, 2012ProPreview
Q4-2011Feb 2, 2012ProPreview
Q3-2011Oct 28, 2011ProPreview
Q2-2011Jul 29, 2011ProPreview
Q1-2011Apr 29, 2011ProPreview
Q4-2010Feb 3, 2011ProPreview
Q3-2010Oct 29, 2010ProPreview
Q2-2010Jul 30, 2010ProPreview
Q1-2010May 4, 2010ProPreview
Q4-2009Feb 16, 2010ProPreview
Q3-2009Oct 22, 2009ProPreview
Q2-2009Jul 21, 2009ProPreview
Q1-2009Apr 21, 2009ProPreview
Q4-2008Feb 3, 2009ProPreview
Q3-2008Oct 22, 2008ProPreview
Q2-2008Jul 21, 2008ProPreview
Q1-2008Apr 21, 2008ProPreview
Q4-2007Jan 30, 2008ProPreview

Next report

Q3-2026

Thu, Oct 29

Before the open

Est. EPS

—

Est. Rev

—

Read the preview

About MRK

Sector
Health Care
Industry
Pharmaceuticals
Market cap
$351.3B

71 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Jul 29, 2025ProPreview
Q1-2025Apr 24, 2025ProPreview
Q4-2024Feb 4, 2025Pro
Preview
Q3-2024Oct 31, 2024ProPreview
Q2-2024Jul 30, 2024ProPreview
Q1-2024Apr 25, 2024ProPreview
Q4-2023Feb 1, 2024ProPreview
Q3-2023Oct 26, 2023ProPreview
Q2-2023Aug 1, 2023ProPreview
Q1-2023Apr 27, 2023ProPreview
Q4-2022Feb 2, 2023ProPreview
Q3-2022Oct 27, 2022ProPreview
Q2-2022Jul 28, 2022ProPreview
Q1-2022Apr 28, 2022ProPreview
Q4-2021Feb 3, 2022ProPreview
Q3-2021Oct 28, 2021ProPreview
Q2-2021Jul 29, 2021ProPreview
Q1-2021Apr 29, 2021ProPreview
Q4-2020Feb 4, 2021ProPreview
Q3-2020Oct 27, 2020ProPreview
Q2-2020Jul 31, 2020ProPreview
Q1-2020Apr 28, 2020ProPreview
Q4-2019Feb 5, 2020ProPreview
Q3-2019Oct 29, 2019ProPreview
Q2-2019Jul 30, 2019ProPreview
Q1-2019Apr 30, 2019ProPreview
Q4-2018Feb 1, 2019ProPreview
Q3-2018Oct 25, 2018ProPreview
Q2-2018Jul 27, 2018ProPreview
Q1-2018May 1, 2018ProPreview
Q4-2017Feb 2, 2018ProPreview
Q3-2017Oct 27, 2017ProPreview
Q2-2017Jul 28, 2017ProPreview
Q1-2017May 2, 2017ProPreview
Q4-2016Feb 2, 2017ProPreview
Q3-2016Oct 25, 2016ProPreview
Q2-2016Jul 29, 2016ProPreview
Q1-2016May 5, 2016ProPreview
Q4-2015Feb 3, 2016ProPreview
Q3-2015Oct 27, 2015ProPreview
Q2-2015Jul 28, 2015ProPreview
Q1-2015Apr 28, 2015ProPreview
Q4-2014Feb 4, 2015ProPreview
Q3-2014Oct 27, 2014ProPreview
Q2-2014Jul 29, 2014ProPreview
Q1-2014Apr 29, 2014ProPreview
Q4-2013Feb 5, 2014ProPreview
Q3-2013Oct 28, 2013ProPreview
Q2-2013Jul 30, 2013ProPreview
Q1-2013May 1, 2013ProPreview
Q4-2012Feb 1, 2013ProPreview
Q3-2012Oct 26, 2012ProPreview
Q2-2012Jul 27, 2012ProPreview
Q1-2012Apr 27, 2012ProPreview
Q4-2011Feb 2, 2012ProPreview
Q3-2011Oct 28, 2011ProPreview
Q2-2011Jul 29, 2011ProPreview
Q1-2011Apr 29, 2011ProPreview
Q4-2010Feb 3, 2011ProPreview
Q3-2010Oct 29, 2010ProPreview
Q2-2010Jul 30, 2010ProPreview
Q1-2010May 4, 2010ProPreview
Q4-2009Feb 16, 2010ProPreview
Q3-2009Oct 22, 2009ProPreview
Q2-2009Jul 21, 2009ProPreview
Q1-2009Apr 21, 2009ProPreview
Q4-2008Feb 3, 2009ProPreview
Q3-2008Oct 22, 2008ProPreview
Q2-2008Jul 21, 2008ProPreview
Q1-2008Apr 21, 2008ProPreview
Q4-2007Jan 30, 2008ProPreview